Although the prevalence of CV risk factors and pre-existing cardiac disease was numerically higher in patients with MACE compared to those without MACE, these differences did not reach statistical significance (trend towards significance for coronary artery disease).
← all excerpts
Cardiovascular events in patients treated with chimeric antigen receptor T-cell therapy for aggressive B-cell lymphoma.
1
—
—